Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2021 Jun;16(6):843-845.
doi: 10.2215/CJN.04460421.

Mineralocorticoid Receptor Antagonists and Cardiovascular Health with Kidney Failure

Qandeel H Soomro  1 , David M Charytan
Affiliations
Editorial

Mineralocorticoid Receptor Antagonists and Cardiovascular Health with Kidney Failure

Qandeel H Soomro et al. Clin J Am Soc Nephrol. 2021 Jun.
No abstract available

Keywords: cardiovascular disease; heart failure; hemodialysis; kidney failure; mineralocorticoid receptor antagonists.

PubMed Disclaimer

Comment on

References

    1. United States Renal Data System: USRDS Annual Data Report: Epidemiology of Kidney Disease in the United States, Bethesda, MD, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, 2020
    1. Briet M, Schiffrin EL: Aldosterone: Effects on the kidney and cardiovascular system. Nat Rev Nephrol 6: 261–273, 2010 - PubMed
    1. Tian J, Shidyak A, Periyasamy SM, Haller S, Taleb M, El-Okdi N, Elkareh J, Gupta S, Gohara S, Fedorova OV, Cooper CJ, Xie Z, Malhotra D, Bagrov AY, Shapiro JI: Spironolactone attenuates experimental uremic cardiomyopathy by antagonizing marinobufagenin [published erratum appears in Hypertension 57: e13, 2011]. Hypertension 54: 1313–1320, 2009 - PMC - PubMed
    1. Oestreicher EM, Martinez-Vasquez D, Stone JR, Jonasson L, Roubsanthisuk W, Mukasa K, Adler GK: Aldosterone and not plasminogen activator inhibitor-1 is a critical mediator of early angiotensin II/NG-nitro-L-arginine methyl ester-induced myocardial injury. Circulation 108: 2517–2523, 2003 - PubMed
    1. Mottram PM, Haluska B, Leano R, Cowley D, Stowasser M, Marwick TH: Effect of aldosterone antagonism on myocardial dysfunction in hypertensive patients with diastolic heart failure. Circulation 110: 558–565, 2004 - PubMed

MeSH terms

Substances

Associated data